Diabetes but not insulin is associated with higher colon cancer mortality

doi:10.3748/wjg.v18.i31.4182

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 31

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4683)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

369

HTML

3731

Figures (1-2)

332

Tables (1-4)

251

Sum=4683

Aug 21, 2012 (publication date) through Feb 27, 2025

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 21, 2012; 18(31): 4182-4190
Published online Aug 21, 2012. doi: 10.3748/wjg.v18.i31.4182

Table 1 Age/sex-specific mortality rates (per 100 000 person-years) for colon cancer in diabetic patients and their mortality rate ratios compared to the average mortality rates in the general population of Taiwan

Age (yr)	Men					Women
	n	N	PY	MR	MRR (95% CI)	n	N	PY	MR	MRR (95% CI)
Original diabetic cohort
Followed from enrollment to the end of 2006
25-54	76	42107	363948.2	20.88	5.69 (4.65, 6.96)^a	43	43749	399556.9	10.76	3.05 (2.29, 4.06)^a
55-64	158	28867	225706.1	70.00	2.75 (2.36, 3.21)^a	146	37317	314033.6	46.49	2.67 (2.27, 3.14)^a
65-74	265	30704	211811.1	125.11	2.01 (1.78, 2.27)^a	238	35194	258155.6	92.19	2.09 (1.84, 2.38)^a
≥ 75	142	11669	59761.6	237.61	1.65 (1.40, 1.95)^a	146	15313	83905.5	174.01	1.46 (1.24, 1.72)^a
Followed from enrollment to the end of 2000
25-54	23	42107	143238.6	16.06	4.38 (3.00, 6.37)^a	16	43749	153584.7	10.42	2.95 (1.84, 4.71)^a
55-64	52	28867	96078	54.12	2.12 (1.62, 2.78)^a	55	37317	129321.2	42.53	2.44 (1.88, 3.17)^a
65-74	112	30704	94488.8	118.53	1.90 (1.58, 2.29)^a	91	35194	113687.6	80.04	1.81 (1.48, 2.23)^a
≥ 75	70	11669	30353.6	230.61	1.60 (1.27, 2.03)^a	75	15313	42092.9	178.18	1.49 (1.19, 1.87)^a
Followed from 2001 to the end of 2006
25-54	30	32626	186021.3	16.13	4.39 (3.16, 6.11)^a	22	34400	201514.2	10.92	3.09 (2.07, 4.60)^a
55-64	68	22743	122446.4	55.53	2.18 (1.72, 2.76)^a	52	29880	167205.9	31.10	1.79 (1.36, 2.34)^a
65-74	172	26548	133463.8	128.87	2.07 (1.78, 2.40)^a	131	33591	176023.3	74.42	1.69 (1.42, 2.00)^a
≥ 75	114	13653	59608.3	191.25	1.33 (1.11, 1.60)^a	131	17808	79994.6	163.76	1.37 (1.16, 1.63)^a
Sub-cohort diabetic patients
Diabetes of any duration at enrollment
25-54	25	13837	100793.2	24.80	6.76 (4.81, 9.50)^a	16	12768	95960.8	16.67	4.72 (3.02, 7.37)^a
55-64	62	12454	84551.8	73.33	2.88 (2.26, 3.66)^a	53	16717	118278.5	44.81	2.57 (1.98, 3.35)^a
65-74	99	12395	76349.6	129.67	2.08 (1.71, 2.53)^a	86	15029	96058.4	89.53	2.03 (1.64, 2.50)^a
≥ 75	42	3574	17710.4	237.15	1.65 (1.22, 2.23)^a	43	4891	25384.8	169.39	1.42 (1.05, 1.91)^a
Diabetes duration < 10 yr at enrollment
25-54	15	11631	86016.8	17.44	4.75 (3.00, 7.53)^a	12	10389	78983.7	15.19	4.30 (2.56, 7.23)^a
55-64	42	8892	61949.1	67.80	2.66 (1.99, 3.57)^a	37	11636	84435.4	43.82	2.52 (1.84, 3.45)^a
65-74	62	7887	49825.0	124.44	2.00 (1.56, 2.55)^a	47	9246	61226.8	76.76	1.74 (1.31, 2.31)^a
≥ 75	29	2138	10946.7	264.92	1.84 (1.29, 2.64)^a	23	2814	15302.6	150.30	1.26 (0.84, 1.90)
Diabetes duration ≥ 10 yr at enrollment
25-54	10	2206	14773	67.69	18.44 (11.81, 28.80)^a	4	2379	16988.5	23.55	6.66 (2.85, 15.56)^a
55-64	20	3562	22608.3	88.46	3.47 (2.30, 5.25)^a	16	5081	33862.5	47.25	2.71 (1.69, 4.35)^a
65-74	37	4508	26541.7	139.40	2.24 (1.63, 3.07)^a	39	5783	34845.7	111.92	2.54 (1.87, 3.44)^a
≥ 75	13	1436	6785.4	191.59	1.33 (0.77, 2.29)	20	2077	10103.5	197.95	1.66 (1.07, 2.56)^a
Sub-cohort type 2 diabetic patients
Diabetes of any duration at enrollment
25-54	23	13239	96635.9	23.80	6.49 (4.54, 9.26)^a	16	12260	92076.3	17.38	4.92 (3.16, 7.66)^a
55-64	60	12082	82183.2	73.01	2.87 (2.24, 3.66)^a	51	16288	115494.5	44.16	2.54 (1.94, 3.32)^a
65-74	92	12051	74413.3	123.63	1.98 (1.62, 2.43)^a	83	14570	93223.1	89.03	2.02 (1.63, 2.50)^a
≥ 75	39	3448	17171.3	227.12	1.58 (1.16, 2.16)^a	43	4756	24716.7	173.97	1.46 (1.08, 1.97)^a
Diabetes duration < 10 yr at enrollment
25-54	14	11248	83333.9	16.80	4.58 (2.84, 7.38)^a	12	10082	76622.8	15.66	4.43 (2.64, 7.44)^a
55-64	40	8730	60901.6	65.68	2.58 (1.91, 3.48)^a	36	11453	83223.4	43.26	2.48 (1.81, 3.42)^a
65-74	59	7742	48999.2	120.41	1.93 (1.50, 2.49)^a	46	9068	60169.4	76.45	1.73 (1.30, 2.31)^a
≥ 75	27	2088	10708.6	252.13	1.75 (1.21, 2.55)^a	23	2760	15063.9	152.68	1.28 (0.85, 1.93)
Diabetes duration ≥ 10 yr at enrollment
25-54	9	1991	13298.7	67.68	18.44 (11.53, 29.50)^a	4	2178	15465.0	25.86	7.32 (3.17, 16.88)^a
55-64	20	3352	21284.3	93.97	3.69 (2.45, 5.56)^a	15	4835	32290.5	46.45	2.67 (1.64, 4.35)^a
65-74	33	4309	25428.1	129.78	2.08 (1.49, 2.91)^a	37	5502	33067.7	111.89	2.53 (1.85, 3.47)^a
≥ 75	12	1360	6484.3	185.06	1.29 (0.73, 2.26)	20	1996	9674.1	206.74	1.73 (1.12, 2.67)^a

^aP < 0.05 vs general population. PY: Person-years; MR: Mortality rate; MRR: Mortality rate ratio; CI: Confidence interval; n: Case number of colon cancer; N: Case number observed.

Table 2 Baseline characteristics of the sub-cohort of diabetic men and women who had been interviewed with a baseline questionnaire

Variable	Men	Women	P value
n	42 260	49 405
Age, yr	59.8 (11.7)	61.5 (10.8)	< 0.0001
Diabetes duration, yr	7.0 (6.6)	7.5 (6.6)	< 0.0001
Diabetes type, % type 1	1440 (3.4)	1531 (3.1)	0.0085
Body mass index, kg/m²	24.4 (3.4)	24.7 (3.8)	< 0.0001
Smoking, % yes	26 522 (62.8)	1703 (3.5)	< 0.0001
Use of insulin, % yes	3717 (8.8)	5059 (10.2)	< 0.0001
Area of residence, % urban	20 231 (47.9)	22 264 (45.1)	< 0.0001
Colon cancer mortality	228 (0.5)	198 (0.4)	0.0021

Data are expressed as mean (SD) or n (%).

Table 3 Cox proportional hazards models showing hazard ratios and 95% confidence intervals for colon cancer mortality in diabetic patients by age before and after exclusion of patients with a duration of < 5 years between onset of diabetes and colon cancer mortality

Variables	Interpretation	Hazard ratio (95% CI)
		Age≥25 yr				Age 25-64 yr		Age≥65 yr
		Unadjusted	P value	Mutually adjusted	P value	Mutually adjusted	P value	Mutually-adjusted	P value
Before exclusion
Age	Every 1-yr increment	1.077 (1.066-1.088)	< 0.0001	1.077 (1.066-1.088)	< 0.0001	1.090 (1.062-1.119)	< 0.0001	1.072 (1.049-1.096)	< 0.0001
Sex	Men vs women	1.395 (1.150-1.691)	0.0007	1.256 (0.976-1.618)	0.0769	1.181 (0.758-1.841)	0.4622	1.288 (0.946-1.753)	0.1081
Diabetes duration	Every 1-yr increment	1.032 (1.019-1.045)	< 0.0001	1.006 (0.992-1.020)	0.3845	0.993 (0.964-1.023)	0.6652	1.009 (0.994-1.025)	0.2329
Diabetes type	Type 2 vs type 1	0.682 (0.430-1.081)	0.1036	0.750 (0.432-1.301)	0.3057	0.914 (0.345-2.425)	0.8574	0.680 (0.348-1.328)	0.2588
Body mass index	Every 1-kg/m² increment	0.956 (0.929-0.984)	0.0021	0.976 (0.948-1.005)	0.1062	0.966 (0.920-1.014)	0.1616	0.981 (0.946-1.018)	0.3080
Smoking	Yes vs no	1.484 (1.219-1.808)	< 0.0001	1.384 (1.068-1.792)	0.0140	1.746 (1.121-2.720)	0.0136	1.215 (0.881-1.676)	0.2351
Insulin use	Yes vs no	1.344 (0.992-1.821)	0.0564	1.235 (0.843-1.809)	0.2782	1.318 (0.686-2.532)	0.4076	1.215 (0.759-1.946)	0.4168
Area of residence	Urban vs rural	0.901 (0.743-1.094)	0.2928	0.852 (0.702-1.034)	0.1046	0.734 (0.530-1.016)	0.0621	0.931 (0.731-1.187)	0.5660
After exclusion
Age	Every 1-yr increment	1.082 (1.070-1.094)	< 0.0001	1.080 (1.068-1.092)	< 0.0001	1.096 (1.064-1.128)	< 0.0001	1.070 (1.046-1.095)	< 0.0001
Sex	Men vs women	1.454 (1.186-1.784)	0.0003	1.281 (0.980-1.676)	0.0704	1.355 (0.836-2.195)	0.2172	1.249 (0.903-1.728)	0.1787
Diabetes duration	Every 1-yr increment	1.046 (1.034-1.059)	< 0.0001	1.021 (1.007-1.034)	0.0022	1.025 (0.996-1.054)	0.0883	1.020 (1.004-1.035)	0.0120
Diabetes type	Type 2 vs type 1	0.640 (0.398-1.028)	0.0647	0.710 (0.402-1.254)	0.2386	0.637 (0.229-1.771)	0.3878	0.737 (0.371-1.465)	0.3837
Body mass index	Every 1-kg/m² increment	0.960 (0.932-0.989)	0.0078	0.984 (0.955-1.015)	0.3034	0.983 (0.933-1.035)	0.5160	0.984 (0.948-1.022)	0.4153
Smoking	Yes vs no	1.555 (1.263-1.914)	< 0.0001	1.445 (1.099-1.899)	0.0083	1.814 (1.130-2.913)	0.0137	1.268 (0.905-1.778)	0.1672
Insulin use	Yes vs no	1.431 (1.044-1.961)	0.0258	1.159 (0.781-1.722)	0.4639	0.927 (0.440-1.954)	0.8419	1.274 (0.798-2.035)	0.3106
Area of residence	Urban vs rural	0.909 (0.741-1.116)	0.3639	0.848 (0.691-1.041)	0.1158	0.815 (0.573-1.158)	0.2536	0.876 (0.680-1.128)	0.3040

CI: Confidence interval.

Table 4 Cox proportional hazards models for mortality from colon cancer by duration of insulin use (reference group: diabetic patients not using insulin) before and after exclusion of patients with a duration of < 5 years between onset of diabetes and colon cancer mortality

	Duration of insulin use
Variables adjusted	<5 yr			5-9 yr			≥10 yr
	HR	95% CI	P value	HR	95% CI	P value	HR	95% CI	P value
Before exclusion
Unadjusted	1.128	0.734-1.735	0.5824	1.245	0.664-2.333	0.4947	1.539	0.918-2.579	0.1018
Age	1.388	0.902-2.136	0.1355	1.487	0.793-2.787	0.2163	1.441	0.860-2.416	0.1654
Sex	1.146	0.745-1.763	0.5339	1.267	0.676-2.375	0.4605	1.562	0.932-2.618	0.0907
Diabetes type	1.101	0.682-1.777	0.6931	0.817	0.362-1.843	0.6259	1.321	0.589-2.964	0.4991
Diabetes duration	1.009	0.655-1.556	0.9663	1.028	0.546-1.935	0.9330	1.018	0.590-1.756	0.9491
Body mass index	1.089	0.707-1.675	0.6995	1.210	0.645-2.268	0.5530	1.505	0.898-2.523	0.1208
Smoking	1.143	0.743-1.759	0.5416	1.263	0.674-2.367	0.4666	1.549	0.924-2.596	0.0966
Area of residence	1.122	0.729-1.726	0.6005	1.237	0.660-2.318	0.5074	1.538	0.918-2.578	0.1023
Full model¹	1.217	0.764-1.937	0.4082	0.943	0.442-2.010	0.8788	1.003	0.454-2.212	0.9948
After exclusion
Unadjusted	1.108	0.698-1.761	0.6630	1.416	0.755-2.656	0.2782	1.746	1.041-2.931	0.0348
Age	1.384	0.871-2.199	0.1696	1.704	0.908-3.197	0.0971	1.633	0.973-2.740	0.0635
Sex	1.129	0.710-1.793	0.6085	1.445	0.771-2.711	0.2510	1.776	1.058-2.981	0.0297
Diabetes type	1.089	0.651-1.821	0.7447	1.010	0.446-2.287	0.9807	1.700	0.770-3.757	0.1893
Diabetes duration	0.943	0.592-1.501	0.8045	1.079	0.573-2.034	0.8133	0.968	0.561-1.669	0.9057
Body mass index	1.072	0.674-1.703	0.7702	1.375	0.733-2.581	0.3215	1.710	1.019-2.870	0.0424
Smoking	1.126	0.708-1.788	0.6164	1.440	0.768-2.701	0.2557	1.760	1.049-2.954	0.0323
Area of residence	1.103	0.694-1.752	0.6786	1.409	0.751-2.643	0.2855	1.746	1.040-2.929	0.0349
Full model¹	1.133	0.691-1.857	0.6214	1.038	0.491-2.195	0.9221	1.003	0.462-2.178	0.9949

¹Adjusted for age, sex, diabetes type, diabetes duration, body mass index, smoking and area of residence. HR: Hazard ratio; CI: Confidence interval.

Citation: Tseng CH. Diabetes but not insulin is associated with higher colon cancer mortality. World J Gastroenterol 2012; 18(31): 4182-4190
URL: https://www.wjgnet.com/1007-9327/full/v18/i31/4182.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i31.4182